Morgan Stanley’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.43M | Sell |
924,676
-852,067
| -48% | -$3.16M | ﹤0.01% | 4355 |
|
|
2025
Q1 | $5.74M | Sell |
1,776,743
-86,314
| -5% | -$279K | ﹤0.01% | 3810 |
|
|
2024
Q4 | $10.4M | Buy |
1,863,057
+160,718
| +9% | +$895K | ﹤0.01% | 3376 |
|
|
2024
Q3 | $18.4M | Buy |
1,702,339
+242,105
| +17% | +$2.62M | ﹤0.01% | 2885 |
|
|
2024
Q2 | $30.7M | Sell |
1,460,234
-89,492
| -6% | -$1.88M | ﹤0.01% | 2212 |
|
|
2024
Q1 | $49.4M | Sell |
1,549,726
-1,587,842
| -51% | -$50.6M | ﹤0.01% | 1772 |
|
|
2023
Q4 | $63.6M | Buy |
3,137,568
+1,671,700
| +114% | +$33.9M | ﹤0.01% | 2203 |
|
|
2023
Q3 | $18.7M | Sell |
1,465,868
-101,891
| -6% | -$1.3M | ﹤0.01% | 2528 |
|
|
2023
Q2 | $28.3M | Sell |
1,567,759
-174,118
| -10% | -$3.15M | ﹤0.01% | 2117 |
|
|
2023
Q1 | $29.9M | Buy |
1,741,877
+283,305
| +19% | +$4.87M | ﹤0.01% | 2012 |
|
|
2022
Q4 | $32.4M | Sell |
1,458,572
-563,001
| -28% | -$12.5M | ﹤0.01% | 1891 |
|
|
2022
Q3 | $16.3M | Buy |
2,021,573
+1,708,534
| +546% | +$13.7M | ﹤0.01% | 2417 |
|
|
2022
Q2 | $2.19M | Sell |
313,039
-106,997
| -25% | -$747K | ﹤0.01% | 4460 |
|
|
2022
Q1 | $6.35M | Sell |
420,036
-14,042
| -3% | -$212K | ﹤0.01% | 3421 |
|
|
2021
Q4 | $9.52M | Buy |
434,078
+65,627
| +18% | +$1.44M | ﹤0.01% | 3001 |
|
|
2021
Q3 | $9.94M | Sell |
368,451
-62,336
| -14% | -$1.68M | ﹤0.01% | 2894 |
|
|
2021
Q2 | $10.4M | Buy |
430,787
+158,641
| +58% | +$3.82M | ﹤0.01% | 2932 |
|
|
2021
Q1 | $11.8M | Buy |
272,146
+26,441
| +11% | +$1.15M | ﹤0.01% | 2487 |
|
|
2020
Q4 | $10.2M | Buy |
+245,705
| New | +$10.2M | ﹤0.01% | 2489 |
|